RT Journal Article
SR Electronic
T1 Evaluating the Experience of Children With Type 1 Diabetes and Their Parents Taking Part in an Artificial Pancreas Clinical Trial Over Multiple Days in a Diabetes Camp Setting
JF Diabetes Care
JO Diabetes Care
FD American Diabetes Association
SP 2158
OP 2164
DO 10.2337/dc16-1073
VO 39
IS 12
A1 Troncone, Alda
A1 Bonfanti, Riccardo
A1 Iafusco, Dario
A1 Rabbone, Ivana
A1 Sabbion, Alberto
A1 Schiaffini, Riccardo
A1 Galderisi, Alfonso
A1 Marigliano, Marco
A1 Rapini, Novella
A1 Rigamonti, Andrea
A1 Tinti, Davide
A1 Vallone, Valeria
A1 Zanfardino, Angela
A1 Boscari, Federico
A1 Del Favero, Simone
A1 Galasso, Silvia
A1 Lanzola, Giordano
A1 Messori, Mirko
A1 Di Palma, Federico
A1 Visentin, Roberto
A1 Calore, Roberta
A1 Leal, Yenny
A1 Magni, Lalo
A1 Losiouk, Eleonora
A1 Chernavvsky, Daniel
A1 Quaglini, Silvana
A1 Cobelli, Claudio
A1 Bruttomesso, Daniela
YR 2016
UL http://care.diabetesjournals.org/content/39/12/2158.abstract
AB OBJECTIVE To explore the experiences of children with type 1 diabetes and their parents taking part in an artificial pancreas (AP) clinical trial during a 7-day summer camp.RESEARCH DESIGN AND METHODS A semistructured interview, composed of 14 questions based on the Technology Acceptance Model, was conducted at the end of the clinical trial. Participants also completed the Diabetes Treatment Satisfaction Questionnaire (DTSQ, parent version) and the AP Acceptance Questionnaire.RESULTS Thirty children, aged 5–9 years, and their parents completed the study. A content analysis of the interviews showed that parents were focused on understanding the mechanisms, risks, and benefits of the new device, whereas the children were focused on the novelty of the new system. The parents’ main concerns about adopting the new system seemed related to the quality of glucose control. The mean scores of DTSQ subscales indicated general parents’ satisfaction (44.24 ± 5.99, range 32–53) and trustful views of diabetes control provided by the new system (7.8 ± 2.2, range 3–12). The AP Acceptance Questionnaire revealed that most parents considered the AP easy to use (70.5%), intended to use it long term (94.0%), and felt that it was apt to improve glucose control (67.0%).CONCLUSIONS Participants manifested a positive attitude toward the AP. Further studies are required to explore participants’ perceptions early in the AP development to individualize the new treatment as much as possible, and to tailor it to respond to their needs and values.